Changes in Beneficial Ownership · 4
Inogen, Inc
INGNNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-09-01
- Issuer
- Inogen Inc
- Issuer CIK
- 0001294133
- Trading symbol
- INGN
- Rule 10b5-1 indication
- Checked
Reporting owner 1
- Name
- Smith Kevin Raymond Merrill
- Reporting owner CIK
- 0001802639
- Relationship
- Director · Officer
- Officer title
- CEO and President
- Address
- C/O INOGEN, INC., 500 CUMMINGS CENTER, SUITE 2800, BEVERLY, MA, 01915
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-09-01 | A · Form 4 | 1,500[F1] | A | 5.33 | 134,962 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Shares acquired through the Company's 2014 Employee Stock Purchase Plan.↩ 1
Signature 1
- Signed
- /s/ Mary Wright, as Attorney-in-Fact
- Date
- 2026-09-03
Company context
Inogen, Inc. (Nasdaq: INGN) is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers and distributors to make its respiratory therapy products widely available, allowing patients the chance to manage the impact of their disease.
Current securities
Recent company filings
- Entry into a Material Definitive Agreement · Regulation FD Disclosure · Other EventsSep 30, 2026
- 10-Q filingAug 7, 2026
- Results of Operations and Financial ConditionAug 6, 2026
- S-8 filingJul 24, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureJul 1, 2026